ALK and neuroblastoma: A 4-year-old male patient with high-risk neuroblastoma (stage 4, N-Myc non-amplified, anaplastic lymphoma kinase [ALK] negative) was initially treated with induction chemotherapy, surgical resection, and adjuvant abdominal proton therapy.